Campaign Against Tuberculosis | 13 Dec 2024

Source: PIB

Recently, the Ministry of Health and Family Welfare has launched a 100-day intensified nationwide campaign to find and treat missing tuberculosis (TB) cases, especially in high-risk groups, and reduce TB deaths significantly. It will be implemented in 347 districts across the country.

About Campaign: The 100-Day Campaign underscores India’s commitment to achieving the goal of end-TB under the National TB Elimination Programme (NTEP).
- It aligns with India’s broader vision to eradicate TB well before the 2030 Sustainable Development Goals deadline.
- National guidelines for the implementation of the new drug-resistant TB regimen – BPaLM were launched to standardize and streamline the administration of this advanced treatment.
  - BPaLM regimen is a novel treatment for Multi-Drug-Resistant TB under the NTEP, consisting of four-drug combination – Bedaquiline, Pretomanid, Linezolid and Moxifloxacin.
- “Ni-kshay Vahaan” – mobile vans to detect and treat patients all over the country were also launched.
Tuberculosis: TB is an infectious disease caused by Mycobacterium tuberculosis, that mainly affects the lungs. It spreads through the air when infected people cough, sneeze or spit.
- As per India TB Report 2024, mortality rate due to Tuberculosis (TB) had declined from 28 per lakh population in 2015 to 23 per lakh population in 2022.
India’s Initiatives against TB: